HEADER CELL CYCLE 01-APR-21 5S9O TITLE CRYSTAL STRUCTURE OF THE HUMAN BRD2 BD1 BROMODOMAIN IN COMPLEX WITH 9- TITLE 2 (CYCLOPROPYLMETHYL)-7-[(2R,6S)-2,6-DIMETHYLMORPHOLINE-4-CARBONYL]-3- TITLE 3 (3,5-DIMETHYL-1,2-OXAZOL-4-YL)-9H-CARBAZOLE-1-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 73-194; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS HELICAL BUNDLE, ACETYL-LYSINE RECOGNITION, ACETYLATED HISTONE H4, KEYWDS 2 NUCLEUS, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 2 17-NOV-21 5S9O 1 JRNL REVDAT 1 29-SEP-21 5S9O 0 JRNL AUTH A.V.GAVAI,D.NORRIS,G.DELUCCA,D.TORTOLANI,J.S.TOKARSKI, JRNL AUTH 2 D.DODD,D.O'MALLEY,Y.ZHAO,C.QUESNELLE,P.GILL,W.VACCARO, JRNL AUTH 3 T.HUYNH,V.AHUJA,W.C.HAN,C.MUSSARI,L.HARIKRISHNAN,M.KAMAU, JRNL AUTH 4 M.POSS,S.SHERIFF,C.YAN,F.MARSILIO,K.MENARD,M.L.WEN, JRNL AUTH 5 R.RAMPULLA,D.R.WU,J.LI,H.ZHANG,P.LI,D.SUN,H.YIP,S.C.TRAEGER, JRNL AUTH 6 Y.ZHANG,A.MATHUR,H.ZHANG,C.HUANG,Z.YANG,A.RANASINGHE, JRNL AUTH 7 G.EVERLOF,N.RAGHAVAN,C.K.TYE,S.WEE,J.T.HUNT,G.VITE, JRNL AUTH 8 R.WESTHOUSE,F.Y.LEE JRNL TITL DISCOVERY AND PRECLINICAL PHARMACOLOGY OF AN ORAL JRNL TITL 2 BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR USING JRNL TITL 3 SCAFFOLD-HOPPING AND STRUCTURE-GUIDED DRUG DESIGN. JRNL REF J.MED.CHEM. V. 64 14247 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34543572 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00625 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 14277 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 730 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2918 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1843 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2742 REMARK 3 BIN R VALUE (WORKING SET) : 0.1815 REMARK 3 BIN FREE R VALUE : 0.2278 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 176 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 95 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.84 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.252 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.276 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.192 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.278 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.193 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2175 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2993 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 754 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 364 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2175 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 257 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2434 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.85 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5S9O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-21. REMARK 100 THE DEPOSITION ID IS D_1001404233. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14315 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 35.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 19.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11500 REMARK 200 FOR THE DATA SET : 22.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 20.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.55300 REMARK 200 FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3AQA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM AMMONIUM CITRATE DIBASIC, REMARK 280 16%(W/V) PEG 3350, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z,-X,-Y REMARK 290 7555 -Z,-X,Y REMARK 290 8555 -Z,X,-Y REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z,-X REMARK 290 11555 Y,-Z,-X REMARK 290 12555 -Y,-Z,X REMARK 290 13555 X+1/2,Y+1/2,Z+1/2 REMARK 290 14555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 15555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 16555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 17555 Z+1/2,X+1/2,Y+1/2 REMARK 290 18555 Z+1/2,-X+1/2,-Y+1/2 REMARK 290 19555 -Z+1/2,-X+1/2,Y+1/2 REMARK 290 20555 -Z+1/2,X+1/2,-Y+1/2 REMARK 290 21555 Y+1/2,Z+1/2,X+1/2 REMARK 290 22555 -Y+1/2,Z+1/2,-X+1/2 REMARK 290 23555 Y+1/2,-Z+1/2,-X+1/2 REMARK 290 24555 -Y+1/2,-Z+1/2,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY1 14 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY1 15 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY2 15 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY1 16 1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY2 16 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY1 17 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY2 17 1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY3 17 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY1 18 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY2 18 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY3 18 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY1 19 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY2 19 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY3 19 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY1 20 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY2 20 1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY3 20 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY1 21 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY2 21 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY3 21 1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY1 22 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY2 22 0.000000 0.000000 1.000000 67.13500 REMARK 290 SMTRY3 22 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY1 23 0.000000 1.000000 0.000000 67.13500 REMARK 290 SMTRY2 23 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY3 23 -1.000000 0.000000 0.000000 67.13500 REMARK 290 SMTRY1 24 0.000000 -1.000000 0.000000 67.13500 REMARK 290 SMTRY2 24 0.000000 0.000000 -1.000000 67.13500 REMARK 290 SMTRY3 24 1.000000 0.000000 0.000000 67.13500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 51 REMARK 465 GLY A 52 REMARK 465 SER A 53 REMARK 465 SER A 54 REMARK 465 HIS A 55 REMARK 465 HIS A 56 REMARK 465 HIS A 57 REMARK 465 HIS A 58 REMARK 465 HIS A 59 REMARK 465 HIS A 60 REMARK 465 SER A 61 REMARK 465 SER A 62 REMARK 465 GLY A 63 REMARK 465 GLU A 64 REMARK 465 THR A 65 REMARK 465 VAL A 66 REMARK 465 ARG A 67 REMARK 465 PHE A 68 REMARK 465 GLN A 69 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 MET B 51 REMARK 465 GLY B 52 REMARK 465 SER B 53 REMARK 465 SER B 54 REMARK 465 HIS B 55 REMARK 465 HIS B 56 REMARK 465 HIS B 57 REMARK 465 HIS B 58 REMARK 465 HIS B 59 REMARK 465 HIS B 60 REMARK 465 SER B 61 REMARK 465 SER B 62 REMARK 465 GLY B 63 REMARK 465 GLU B 64 REMARK 465 THR B 65 REMARK 465 VAL B 66 REMARK 465 ARG B 67 REMARK 465 PHE B 68 REMARK 465 GLN B 69 REMARK 465 GLY B 70 REMARK 465 HIS B 71 REMARK 465 MET B 72 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 GLU B 183 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 85 -61.73 -105.78 REMARK 500 LEU A 110 73.50 -118.24 REMARK 500 VAL B 85 -61.49 -106.11 REMARK 500 LEU B 110 73.91 -115.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW1 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YW1 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 304 DBREF1 5S9O A 73 194 UNP A0A140T9E9_HUMAN DBREF2 5S9O A A0A140T9E9 79 200 DBREF1 5S9O B 73 194 UNP A0A140T9E9_HUMAN DBREF2 5S9O B A0A140T9E9 79 200 SEQADV 5S9O MET A 51 UNP A0A140T9E INITIATING METHIONINE SEQADV 5S9O GLY A 52 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER A 53 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER A 54 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 55 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 56 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 57 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 58 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 59 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 60 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER A 61 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER A 62 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLY A 63 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLU A 64 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O THR A 65 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O VAL A 66 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O ARG A 67 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O PHE A 68 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLN A 69 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLY A 70 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS A 71 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O MET A 72 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O MET B 51 UNP A0A140T9E INITIATING METHIONINE SEQADV 5S9O GLY B 52 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER B 53 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER B 54 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 55 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 56 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 57 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 58 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 59 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 60 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER B 61 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O SER B 62 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLY B 63 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLU B 64 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O THR B 65 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O VAL B 66 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O ARG B 67 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O PHE B 68 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLN B 69 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O GLY B 70 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O HIS B 71 UNP A0A140T9E EXPRESSION TAG SEQADV 5S9O MET B 72 UNP A0A140T9E EXPRESSION TAG SEQRES 1 A 144 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 144 GLU THR VAL ARG PHE GLN GLY HIS MET GLY ARG VAL THR SEQRES 3 A 144 ASN GLN LEU GLN TYR LEU HIS LYS VAL VAL MET LYS ALA SEQRES 4 A 144 LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE ARG GLN PRO SEQRES 5 A 144 VAL ASP ALA VAL LYS LEU GLY LEU PRO ASP TYR HIS LYS SEQRES 6 A 144 ILE ILE LYS GLN PRO MET ASP MET GLY THR ILE LYS ARG SEQRES 7 A 144 ARG LEU GLU ASN ASN TYR TYR TRP ALA ALA SER GLU CYS SEQRES 8 A 144 MET GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR ILE SEQRES 9 A 144 TYR ASN LYS PRO THR ASP ASP ILE VAL LEU MET ALA GLN SEQRES 10 A 144 THR LEU GLU LYS ILE PHE LEU GLN LYS VAL ALA SER MET SEQRES 11 A 144 PRO GLN GLU GLU GLN GLU LEU VAL VAL THR ILE PRO LYS SEQRES 12 A 144 ASN SEQRES 1 B 144 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 144 GLU THR VAL ARG PHE GLN GLY HIS MET GLY ARG VAL THR SEQRES 3 B 144 ASN GLN LEU GLN TYR LEU HIS LYS VAL VAL MET LYS ALA SEQRES 4 B 144 LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE ARG GLN PRO SEQRES 5 B 144 VAL ASP ALA VAL LYS LEU GLY LEU PRO ASP TYR HIS LYS SEQRES 6 B 144 ILE ILE LYS GLN PRO MET ASP MET GLY THR ILE LYS ARG SEQRES 7 B 144 ARG LEU GLU ASN ASN TYR TYR TRP ALA ALA SER GLU CYS SEQRES 8 B 144 MET GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR ILE SEQRES 9 B 144 TYR ASN LYS PRO THR ASP ASP ILE VAL LEU MET ALA GLN SEQRES 10 B 144 THR LEU GLU LYS ILE PHE LEU GLN LYS VAL ALA SER MET SEQRES 11 B 144 PRO GLN GLU GLU GLN GLU LEU VAL VAL THR ILE PRO LYS SEQRES 12 B 144 ASN HET YW1 A 301 69 HET EDO A 302 4 HET EDO A 303 4 HET EDO A 304 4 HET EDO A 305 4 HET EDO A 306 4 HET EDO A 307 4 HET YW1 B 301 69 HET EDO B 302 4 HET EDO B 303 4 HET EDO B 304 4 HETNAM YW1 9-(CYCLOPROPYLMETHYL)-7-[(2R,6S)-2,6- HETNAM 2 YW1 DIMETHYLMORPHOLINE-4-CARBONYL]-3-(3,5-DIMETHYL-1,2- HETNAM 3 YW1 OXAZOL-4-YL)-9H-CARBAZOLE-1-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 YW1 2(C29 H32 N4 O4) FORMUL 4 EDO 9(C2 H6 O2) FORMUL 14 HOH *95(H2 O) HELIX 1 AA1 THR A 76 VAL A 85 1 10 HELIX 2 AA2 VAL A 85 LYS A 92 1 8 HELIX 3 AA3 ALA A 96 ARG A 100 5 5 HELIX 4 AA4 ASP A 104 GLY A 109 1 6 HELIX 5 AA5 ASP A 112 ILE A 117 1 6 HELIX 6 AA6 ASP A 122 ASN A 132 1 11 HELIX 7 AA7 ALA A 137 ASN A 156 1 20 HELIX 8 AA8 ASP A 160 SER A 179 1 20 HELIX 9 AA9 THR B 76 VAL B 85 1 10 HELIX 10 AB1 VAL B 85 LYS B 92 1 8 HELIX 11 AB2 ALA B 96 ARG B 100 5 5 HELIX 12 AB3 ASP B 104 GLY B 109 1 6 HELIX 13 AB4 ASP B 112 ILE B 117 1 6 HELIX 14 AB5 ASP B 122 ASN B 132 1 11 HELIX 15 AB6 ALA B 137 ASN B 156 1 20 HELIX 16 AB7 ASP B 160 SER B 179 1 20 SITE 1 AC1 12 TRP A 97 PRO A 98 PHE A 99 GLN A 101 SITE 2 AC1 12 PRO A 102 VAL A 103 ASP A 104 ASN A 156 SITE 3 AC1 12 EDO A 302 HOH A 405 VAL B 106 LYS B 107 SITE 1 AC2 5 ASP A 160 ASP A 161 ILE A 162 YW1 A 301 SITE 2 AC2 5 EDO A 303 SITE 1 AC3 6 THR A 159 ASP A 160 ASP A 161 EDO A 302 SITE 2 AC3 6 PRO B 111 HOH B 405 SITE 1 AC4 6 ARG A 74 GLU A 184 HOH A 421 LEU B 108 SITE 2 AC4 6 GLY B 109 EDO B 303 SITE 1 AC5 4 TYR A 155 ASN A 156 LYS A 157 ASP A 160 SITE 1 AC6 5 SER A 139 MET A 142 GLN A 143 LYS B 171 SITE 2 AC6 5 GLN B 175 SITE 1 AC7 5 ILE A 116 ILE A 117 LYS A 118 GLN A 119 SITE 2 AC7 5 ASN A 151 SITE 1 AC8 17 HIS A 71 MET A 72 GLN A 94 TRP A 136 SITE 2 AC8 17 GLU A 140 PRO B 98 PHE B 99 GLN B 101 SITE 3 AC8 17 PRO B 102 VAL B 103 ASP B 104 LYS B 107 SITE 4 AC8 17 LEU B 108 LEU B 110 ASN B 156 HOH B 404 SITE 5 AC8 17 HOH B 429 SITE 1 AC9 6 ILE B 116 ILE B 117 LYS B 118 GLN B 119 SITE 2 AC9 6 ASN B 151 HOH B 402 SITE 1 AD1 4 GLU A 186 EDO A 304 TYR B 155 LYS B 157 SITE 1 AD2 3 LYS A 107 LYS B 176 HOH B 419 CRYST1 134.270 134.270 134.270 90.00 90.00 90.00 I 2 3 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007448 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007448 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007448 0.00000